Why does the PE firm care about your product roadmap?

This episode explores the product strategy review process employed by ParkerGale, a private equity firm, to guide its portfolio companies' product development. Against the backdrop of limited resources and the need for strategic prioritization, the discussion centers on how ParkerGale helps its portfolio companies define the "why" behind product enhancements and measure their outcomes. More significantly, the hosts delve into the five key reasons companies enhance existing products: protecting their competitive advantage, increasing sales to existing customers, stealing market share from competitors, acquiring new customers, and attracting late adopters. For instance, the example of a specialized dental accounting software is used to illustrate these different scenarios. The process involves four-to-six-hour meetings with cross-functional teams, focusing on the intent, validation, and prioritization of roadmap items, rather than micromanaging sprints. Ultimately, this structured approach aims to align internal stakeholders, ensure realistic revenue projections, and foster continuous improvement through data-driven analysis of product performance and customer behavior. What this means for other private equity firms is a model for proactively shaping product strategy within portfolio companies to drive revenue growth and maximize value creation.